Factor Analysis
Volatility
Momentum
Value
Quality
Key Metrics
P/E
P/B
Div Yield
Price
Performance Returns Matrix
High volatility
Significant move
Strong month
Excellent quarter
Outstanding year
Strong long-term
Excellent long-term
Technical Analysis
Quantitative Data Matrix & Analysis
Relative Strength Matrix & Analysis
Z-Score Charts
Seasonality Analysis
Corporate Actions & Events
Sign Up to View Full Analysis
Get access to performance matrices, advanced technical indicators, seasonality patterns, and historical event timelines.
Alivus Life Sciences Limited FAQs
Live market prices, valuation metrics, 52-week ranges, and financial information for Alivus Life Sciences Limited.
What is the share price of Alivus Life Sciences Limited today?
Alivus Life Sciences Limited share price today is ₹1,520.70. The stock is currently up by 2.66% from its previous close of ₹1,481.30. Today’s trading range is ₹1,450.10 to ₹1,529.00.
What is the 52-week high and low of Alivus Life Sciences Limited?
Alivus Life Sciences Limited’s 52-week high is ₹1,529.00 and its 52-week low is ₹819.00. At the current price of ₹1,520.70, the stock is 0.54% below its 52-week high and 85.68% above its 52-week low.
What is the market cap of Alivus Life Sciences Limited?
Alivus Life Sciences Limited has a market capitalisation of approximately ₹17,799.51 crore, based on its current share price and outstanding shares. It is classified as a small-cap company.
What is the PE ratio and EPS of Alivus Life Sciences Limited?
Alivus Life Sciences Limited’s current P/E ratio is approximately 26.60x with an estimated trailing EPS of ₹57.18 per share.
What is the dividend yield of Alivus Life Sciences Limited?
Alivus Life Sciences Limited has a dividend yield of approximately 35.00% based on its latest dividend and current share price. The company paid an estimated dividend of ₹532.25 per share over the latest financial period.
What are the valuation metrics P/B and Price-to-Sales for Alivus Life Sciences Limited?
Alivus Life Sciences Limited currently trades at a Price-to-Book (P/B) ratio of 4.90x and a Price-to-Sales (P/S) ratio of 6.76x.